Zero Revenue / Widening LossesPersistent zero revenue and enlarging annual losses indicate the business remains pre‑commercial and unable to monetize its technology. Over a multi‑month horizon this amplifies execution risk, pressures cash reserves, and raises the bar for successful product commercialization.
Consistent Negative Operating & Free Cash FlowRepeated negative operating and free cash flow mean the company cannot self‑fund development or scale manufacturing. Long‑term dependence on external capital increases dilution risk, may slow product rollouts, and constrains strategic flexibility if markets tighten.
Eroding Equity And Negative Returns On EquityDeclining equity and materially negative ROE signal value erosion and capital destruction. Structurally, this makes future fundraising more dilutive and costly, undermining shareholder value and reducing the cushion available for operational setbacks during commercialization.